These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7023947)

  • 1. Long-term treatment of congestive heart failure by captopril: hemodynamic, biological and clinical effects.
    Kayanakis JG; Fauvel JM; Giraud P; Bounhoure JP
    Eur Heart J; 1981 Feb; 2(1):75-81. PubMed ID: 7023947
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors predicting acute and long-term response to captopril therapy in congestive heart failure.
    Levine TB; Cohn JN
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):169S-174S. PubMed ID: 6753898
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of severe chronic cardiac congestive insufficiency with captopril. Short and long-term clinical, hemodynamic and biological effects].
    Lavigne G; Morand P
    Arch Mal Coeur Vaiss; 1982 Mar; 75(3):339-48. PubMed ID: 6807251
    [No Abstract]   [Full Text] [Related]  

  • 4. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.
    Ader R; Chatterjee K; Ports T; Brundage B; Hiramatsu B; Parmley W
    Circulation; 1980 May; 61(5):931-7. PubMed ID: 6244906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response.
    Chatterjee K; Parmley WW; Cohn JN; Levine TB; Awan NA; Mason DT; Faxon DP; Creager M; Gavras HP; Fouad FM
    Am Heart J; 1985 Aug; 110(2):439-47. PubMed ID: 3895877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical, hemodynamic, plethysmographic and biological effects of the oral converting enzyme inhibitor, captopril (SQ 14225), in the short and medium-team treatment of advanced congestive cardiac failure].
    Kayanakis JG; Fauvel JM; Giraud P; Boccalon H; Puel J; Cassagneau B; Bounhoure JP
    Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1325-32. PubMed ID: 6797371
    [No Abstract]   [Full Text] [Related]  

  • 7. Short and long-term effects of treatment with low dose captopril in patients with severe congestive heart failure.
    Dahlström U; Karlberg BE
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):231S-235S. PubMed ID: 6753905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure.
    Kramer B; Topic N; Massie B
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):143S-151S. PubMed ID: 6753895
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemodynamic and hormonal responses during captopril therapy for heart failure: acute, chronic and withdrawal studies.
    Nicholls MG; Ikram H; Espiner EA; Maslowski AH; Scandrett MS; Penman T
    Am J Cardiol; 1982 Apr; 49(6):1497-501. PubMed ID: 6803564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure.
    Ricci S; Zaniol P; Teglio V; Baraldi P; Mattioli G
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):209S-215S. PubMed ID: 6291564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Captopril--a new treatment for severe congestive heart failure.
    Kendall MJ; Smith SR; Thomson MH
    J Clin Hosp Pharm; 1982 Dec; 7(4):231-44. PubMed ID: 6761368
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term hemodynamic and clinical efficacy of captopril therapy in ambulatory management of severe chronic congestive heart failure.
    Awan NA; Amsterdam EA; Hermanovich J; Bommer WJ; Needham KE; Mason DT
    Am Heart J; 1982 Apr; 103(4 Pt 1):474-9. PubMed ID: 6801943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of congestive heart failure with captopril].
    Zheng DY
    Zhonghua Nei Ke Za Zhi; 1984 Jan; 23(1):5-9, 61. PubMed ID: 6396047
    [No Abstract]   [Full Text] [Related]  

  • 14. [Captopril in the treatment of severe congestive heart failure. Experience with 10 patients].
    Escobar E; Ojeda G; Saavedra M; Thumala A
    Rev Med Chil; 1983 Nov; 111(11):1123-9. PubMed ID: 6379801
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute and chronic effects of captopril therapy in patients with refractory heart failure.
    Walsh WF; Lee CL
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):153S-159S. PubMed ID: 6753896
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term control of congestive heart failure with captopril.
    Fouad FM; Tarazi RC; Bravo EL; Hart NJ; Castle LW; Salcedo EE
    Am J Cardiol; 1982 Apr; 49(6):1489-96. PubMed ID: 6803563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure.
    Packer M; Medina N; Yushak M; Meller J
    Circulation; 1983 Oct; 68(4):803-12. PubMed ID: 6352079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperkinetic circulation associated with captopril therapy for congestive heart failure.
    Fouad FM; Salcedo EE; Saragoca M; Bravo EL; Tarazi RC
    N Engl J Med; 1981 Aug; 305(7):405-6. PubMed ID: 7019709
    [No Abstract]   [Full Text] [Related]  

  • 19. [Favorable hemodynamic effects of captopril in chronic refractory cardiac decompensation].
    Ansalone G; Bellocci F; Scabbia E; Schiavoni G; Loperfido F; Zecchi P
    Cardiologia; 1982; 27(3):263-9. PubMed ID: 6765277
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and haemodynamic responses to captopril and hydralazine in chronic congestive heart failure: the importance of preload reduction.
    Fitzgerald DJ; O'Callaghan WG; O'Malley K; Horgan J; O'Brien E
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):217S-222S. PubMed ID: 6753903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.